La Jolla Institute for Immunology identified potential targets for immune responses to novel coronavirus
On Mar. 11, 2020, the La Jolla Institute for Immunology (LJI) and the J. Craig Venter Institute announced…
On Mar. 11, 2020, the La Jolla Institute for Immunology (LJI) and the J. Craig Venter Institute announced…
On Mar. 10, 2020, CaroGen and scientists from Yale announced they had begun work on a vaccine targeting…
On Mar. 10, 2020, Innovation Pharma announced that management was advised that testing of Brilacidin, the Company’s flagship…
On Mar. 10, 2020, BCerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2…
On Mar. 9, 2020, Innovation Pharmaceuticals announced it was notified by one of the 12 Regional Biocontainment Labs…
On Mar. 9, 2020, AIM ImmunoTech announced that the National Institute of Infectious Diseases (NIID) in Japan will…
On Mar. 6, 2020, Mount Sinai Health System and Harbour BioMed (HBM) announced a multi-year, multifaceted collaboration to…
On Mar. 5, 2020, Hologic announced a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on…
On Mar. 4, 2020, Vir Biotech and Alnylam Pharmaceuticals announced an expansion of their existing collaboration to include…
On Mar. 4, 2020, Luminex announced they were working on multiple solutions to augment their NxTAG and ARIES…
On Mar. 4, 2020, the UW Medicine Clinical Virology Lab announced it had received U.S. Food and Drug…
On Mar. 3, 2020, Heat Biologics announced the Company has formally launched a program within its wholly-owned subsidiary,…
On Feb. 29, 2020, the University of Washington (UW) Medicine Clinical Virology Lab announced it had received U.S….
On Feb. 28, 2020, immediately after Christian Drosten published a genetic sequence of the novel coronavirus online, he…
On Feb. 28, 2020, Altimmune announced the advancement of a novel single-dose, intranasal vaccine using Altimmune’s proprietary technology…
On Feb. 26, 2020, the National Institute of Allergy and Infectious Diseases’ Rocky Mountain Laboratories (NIAID-RML) announced it…
On Feb. 25, 2020, a University of British Columbia (UBC) researcher was part of an international team working…
On Feb. 25, 2020, Vir Biotech and WuXi Biologics announced a development and manufacturing collaboration to advance and…
On Feb. 24, 2020, researchers at National Institute of Allergy and Infectious Disease’s Rocky Mountain Laboratories in Hamilton,…
On Feb. 24, 2020, Scientists at Texas Biomed began work on the novel coronavirus known as SARS-CoV-2. A…
On Feb. 24, 2020, researchers reported that the spikes crowning the new coronavirus that causes COVID-19 atypical pneumonia…
On Feb. 19, 2020, NIAID scientists working with investigators from the University of Texas at Austin identified the…
On Feb. 18, 2020, Sanofi announced it had leveraged previous development work for a SARS vaccine which may…
On Feb. 12, 2020, Vir Biotech announced it had identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2…
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
On Dec. 31, 2019, the World Health Organization (WHO) declared the Coronavirus outbreak a global pandemic. To date,…
On Aug. 1, 2014, the U.S. Centers for Disease Control and Prevention (CDC) initiated the Global Heath Security…
On May 5, 2010, Lawrence Livermore National Laboratory (LLNL) biologists and informatics experts announced the Lawrence Livermore Microbial…
On Apr. 15, 2009, Oregon Health & Science University (OHSU) and the University of Washington (UW), along with…
In January 2007, scientists at the University of Iowa reported in the Journal of Virology that they had…